Blog

Proposed Guideline on LMWHs in Biosimilars

Mon, 05 Aug 2013 16:22:00 GMT

The European Medicines Agency (EMA) announced on 31 January 2013 that it had released a draft guideline to revise the agency’s current guideline on biosimilars containing low molecular weight heparins (LMWHs), a type of medical product often used...

Complete the Biocompatible Polymer Brands Survey for Your Chance to Win an iPad

Mon, 22 Jul 2013 12:30:00 GMT

Our sister publication Medical Plastics News needs your opinions on a range of biocompatible polymer brands. The independent research organisation DJS Research is working on behalf of MPN to perform a poll of the medical plastic processing community.

Regulatory Affairs Vs Regulatory Sciences

Thu, 20 Jun 2013 11:53:00 GMT

Regulatory affairs is a comparatively new profession that developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical...

Achieving Fast and Economical Production of High Quality Tablets

Thu, 20 Jun 2013 10:12:00 GMT

The tablet remains the most popular dosage form and tabletting equipment has evolved significantly over the last decade to accommodate the ongoing demand for its advancement. Big pharma and their generic opponents increasingly seek to gain the...

API GMP Requirements Update

Mon, 29 Apr 2013 11:49:00 GMT

In order to ensure that APIs meet the requirements for quality and purity that they purport or are represented to possess, the Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (Q7) was developed by the International...

EPM’s First Visit to TechnoPharm and POWTECH

Fri, 26 Apr 2013 15:34:00 GMT

The EPM team has just returned from the TechnoPharm and POWTECH show in Nuremberg. It was our first time at the event and in Bavaria’s second largest city, which dates back to the 11th century and is famous for the post-WWII Nuremberg trials.

I Holland's R&D Manager Gives Lowdown on Anti-Sticking Project

Thu, 11 Apr 2013 13:52:00 GMT

In January 2012, I Holland and the University of Nottingham’s School of Pharmacy launched the two-year TSAR (Tabletting Science Anti-Stick Research) project to investigate and solve the most common tabletting issue of formulation ‘sticking’ to...

Biosimilars Sector from EU and US Perspectives

Tue, 26 Mar 2013 12:10:00 GMT

Biosimilar medicines, one of the fastest growing sectors of the industry, constitute a major share of pharmaceutical expenditure in the EU, the US and globally. From a regulatory perspective, they are a new paradigm in drug development, similarly...

Fancy Joining EPM's EAB?

Wed, 20 Mar 2013 12:09:00 GMT

I'm always keen to hear from individuals interested in joining the magazine's Editorial Advisory Board (EAB).

Are You Involved in Tablet Production?

Mon, 25 Feb 2013 11:59:00 GMT

As you may be aware, we will be featuring a tabletting roundtable in the June issue of EPM, so I thought I would take this opportunity to ask you, our esteemed audience, whether there are any questions you would like put to our panel...

Welcome to the New EPM Website

Tue, 05 Feb 2013 20:27:00 GMT

Hi everyone and welcome to our new and much improved website. The one-stop-shop for pretty much everything that makes up the pharmaceutical manufacturing supply chain.

Asia's Changing Regulatory Environment and Pharma Outsourcing

Mon, 14 Jan 2013 14:45:00 GMT

Asia is the fastest growing pharmaceutical market in the world, providing significant opportunities for drug development and marketing. Consequently, pharmaceutical regulations in this region are fast gaining attention...

Extractables, Leachables and QbD

Tue, 20 Nov 2012 17:29:00 GMT

Extractables and leachables are increasingly becoming a cause of major concern for both the pharmaceutical industry and regulatory bodies. The development of unique packaging, novel formulations and drug-coated medical devices has exacerbated...